Novaccess Global Inc (XSNX)
0.015
+0.01
(+80.72%)
USD |
OTCM |
May 17, 16:00
Novaccess Global Total Liabilities (Quarterly): 6.446M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.446M |
September 30, 2023 | 7.861M |
June 30, 2023 | 6.41M |
March 31, 2023 | 5.830M |
December 31, 2022 | 7.085M |
September 30, 2022 | 4.778M |
June 30, 2022 | 4.793M |
March 31, 2022 | 4.682M |
December 31, 2021 | 4.027M |
September 30, 2021 | 4.136M |
June 30, 2021 | 4.485M |
March 31, 2021 | 2.729M |
December 31, 2020 | 2.310M |
September 30, 2020 | 3.570M |
June 30, 2020 | 1.193M |
March 31, 2020 | 2.508M |
December 31, 2019 | 2.809M |
September 30, 2019 | 2.451M |
June 30, 2019 | 3.430M |
March 31, 2019 | 2.941M |
December 31, 2018 | 3.421M |
September 30, 2018 | 4.792M |
June 30, 2018 | 7.701M |
March 31, 2018 | 1.309M |
December 31, 2017 | 0.9544M |
Date | Value |
---|---|
September 30, 2017 | 1.092M |
June 30, 2017 | 0.8767M |
March 31, 2017 | 1.003M |
December 31, 2016 | 0.9939M |
September 30, 2016 | 0.9063M |
June 30, 2016 | 0.8295M |
March 31, 2016 | 0.7977M |
December 31, 2015 | 1.018M |
September 30, 2015 | 0.9741M |
June 30, 2015 | 0.6451M |
March 31, 2015 | 0.7903M |
December 31, 2014 | 1.014M |
September 30, 2014 | 0.9722M |
June 30, 2014 | 0.979M |
March 31, 2014 | 1.085M |
December 31, 2013 | 1.022M |
September 30, 2013 | 0.9441M |
June 30, 2013 | 0.9827M |
March 31, 2013 | 1.004M |
December 31, 2012 | 0.9747M |
September 30, 2012 | 0.7517M |
June 30, 2012 | 0.7746M |
March 31, 2012 | 0.7888M |
December 31, 2011 | 0.6381M |
September 30, 2011 | 0.7298M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.193M
Minimum
Jun 2020
7.861M
Maximum
Sep 2023
4.291M
Average
4.136M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
CEL-SCI Corp | 15.74M |
AIM ImmunoTech Inc | 9.147M |
IGC Pharma Inc | 2.206M |
NovaBay Pharmaceuticals Inc | 5.197M |
Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.0173M |
Shareholders Equity (Quarterly) | -6.429M |